Big Law
Pfizer Finalizes Its $6.7 Billion Arena Pharmaceuticals Acquisition
Pfizer has concluded the takeover of the complete outstanding shares, options and restricted stock units of clinical-stage firm Arena Pharmaceuticals for an equity price of nearly $6.7bn or $100 for each share in cash.
In December last year, Pfizer entered a definitive agreement to acquire Arena.
Arena develops novel therapies to treat various immuno-inflammatory ailments.
